The Journal of Neuroscience, August 1, 1999, 19(15):6588-6598
Evidence for Tonic Activation of NK-1 Receptors during the Second
Phase of the Formalin Test in the Rat
J. L.
Henry1, 2,
K.
Yashpal2, 4,
G. M.
Pitcher1,
J.-G.
Chabot2, 6, and
T. J.
Coderre3, 4, 5
1 Department of Physiology, McGill University,
Montreal, Quebec, H3G 1Y6 Canada, 2 Department of
Psychiatry, McGill University, Montreal, Quebec, H3A 1A1 Canada,
3 Department of Psychology, McGill University, Montreal,
Quebec, H3A 1B1 Canada, 4 Pain Mechanisms Laboratory,
Clinical Research Institute of Montreal, Montreal, Quebec, H2W 1R7
Canada, 5 Département de Médecine,
Université de Montréal, Montreal, Quebec, H3C 3J7 Canada,
and 6 Douglas Hospital Research Centre, Verdun, Quebec, H4H
1R3 Canada
Behavioral, electrophysiological, and autoradiographic experiments
were done to study the second nociceptive phase in the formalin test.
In initial experiments, this second phase was attenuated by 1-10 mg of
the NK-1 receptor antagonist CP-99,994, given subcutaneously 10, 30, or
60 min before formalin (n = 8-10) and by 20 µg
given intrathecally 20 min after formalin (n = 13);
the inactive isomer CP-100,263 was ineffective. In electrophysiological
experiments on single dorsal horn neurons in vivo, the
excitatory responses to subcutaneous formalin injection (50 µl,
2.5%) were attenuated by subsequent intravenously administration of
the NK-1 receptor antagonist CP-96,345 (0.5 mg/kg;
n = 8), given 35-40 min after formalin, but not by
the inactive enantiomer CP-96,344 (0.5 mg/kg; n = 9). Finally, autoradiographic binding of
exogenous [125I]BH-substance P in the lumbar cord
was reduced at 5 and 25 min after formalin (50 µl, 1 or 5%), with an
intermediate level of reduction at 12 min. These data are interpreted
as evidence that the second phase of nociceptive scores in the formalin
test is attributable at least partially to tonic activation of NK-1
receptors at the spinal level, whether because of a temporally limited
release of substance P, for example only during the first phase, but a slow removal or breakdown of substance P, or, more likely, because of
tonic release from primary afferents throughout the second phase.
Irrespective of the mechanism, it can be concluded that at least some
of the persistent nociceptive effects associated with peripheral
inflammation, or at least those provoked by subcutaneous injection of
formalin, are mediated via continuous activation of NK-1 receptors at
the level of the spinal dorsal horn; this may relate directly to
mechanisms underlying prolonged nociceptive pains in humans.
Key words:
substance P; substance P receptor; NK-1 receptor; tachykinin; substance P antagonist; CP-96,345; CP-99,994; nociception; formalin test; wide dynamic range neuron; dorsal horn; spinal cord; intrathecal; binding; autoradiography
Copyright © 1999 Society for Neuroscience 0270-6474/99/19156588-11$05.00/0